Endometrial adult/progenitor stem cells: Pathogenetic theory and new antiangiogenic approach for endometriosis therapy

Reproductive Sciences

Volumn 21, Issue 3, 2014, Pages 296-304

  Pittatore, G ^a   Moggio, A ^a   Benedetto, C ^a   Bussolati, B ^a   Revelli, A ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

adult stem cells; angiogenesis; antiangiogenic drugs; endometrial stem cells; endometriosis

Indexed keywords

ANGIOGENESIS INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; STEROID RECEPTOR; VASCULOTROPIN INHIBITOR;

ADULT STEM CELL; ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTIANGIOGENIC THERAPY; CELL ISOLATION; CELL PROLIFERATION; CELL REGENERATION; CELL RENEWAL; CELL SURVIVAL; ENDOMETRIOSIS; ENDOMETRIUM CELL; HORMONAL THERAPY; HUMAN; MESENCHYMAL STEM CELL; NONHUMAN; PATHOGENESIS; PERITONEAL CAVITY; PRIORITY JOURNAL; REVIEW; STROMA CELL; TISSUE SURVIVAL; CELL DIFFERENTIATION; CELL INVASION;

ADULT STEM CELLS; ANGIOGENESIS; ANTIANGIOGENIC DRUGS; ENDOMETRIAL STEM CELLS; ENDOMETRIOSIS;

ADULT; ADULT STEM CELLS; ANGIOGENESIS INHIBITORS; ANIMALS; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; NIACINAMIDE; PHENYLUREA COMPOUNDS;

EID: 84896836500     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719113503405     Document Type: Review

References (91)

1. Bulun SE. Endometriosis. N Engl J Med. 2009; 360 (3). 268-279
2. Revelli A, Modotti M, Ansaldi C, Massobrio M. Recurrent endometriosis: a review of biological and clinical aspects. Obstet Gynecol Surv. 1995; 50 (10). 747-754
3. Laschke MW, Menger MD. In vitro and in vivo approaches to study angiogenesis in the pathophysiology and therapy of endometriosis. Hum Reprod Update. 2007; 13 (4). 331-342
4. Taylor RN, Yu J, Torres PB, et al. Mechanistic and therapeutic implications of angiogenesis in endometriosis. Reprod Sci. 2009; 16 (2). 140-146
5. Kao AP, Wang KH, Chang CC, et al. Comparative study of human eutopic and ectopic endometrial mesenchymal stem cells and the development of an in vivo endometriotic invasion model. Fertil Steril. 2011; 95 (4). 1308-1315
6. Hull ML, Charnock-Jones DS, Chan CL, et al. Antiangiogenic agents are effective inhibitors of endometriosis. J Clin Endocrinol Metab. 2003; 88 (6). 2889-2899
7. Van Langendonckt A, Donnez J, Defrère S, Dunselman GA, Groothuis PG. Antiangiogenic and vascular-disrupting agents in endometriosis: pitfalls and promises. Mol Hum Reprod. 2008; 14 (5). 259-268
8. Chan RW, Schwab KE, Gargett CE. Clonogenicity of human endometrial epithelial and stromal cells. Biol Reprod. 2004; 70 (6). 1738-1750
9. Schwab KE, Chan RW, Gargett CE. Putative stem cell activity of human endometrial epithelial and stromal cells during the menstrual cycle. Fertil Steril. 2005; 84 (suppl 2). 1124-1130
10. Chan RW, Gargett CE. Identification of label-retaining cells in mouse endometrium. Stem Cells. 2006; 24 (6). 1529-1538
11. Cervelló I, Martínez-Conejero JA, Horcajadas JA, Pellicer A, Simón C. Identification, characterization and co-localization of label-retaining cell population in mouse endometrium with typical undifferentiated markers. Hum Reprod. 2007; 22 (1). 45-51
12. Kato K, Yoshimoto M, Kato K, et al. Characterization of side-population cells in human normal endometrium. Hum Reprod. 2007; 22 (5). 1214-1223
13. Dimitrov R, Timeva T, Kyurkchiev D, et al. Characterization of clonogenic stromal cells isolated from human endometrium. Reproduction. 2008; 135 (4). 551-558
14. Gargett CE, Schwab KE, Zillwood RM, Nguyen HP, Wu D. Isolation and culture of epithelial progenitors and mesenchymal stem cells from human endometrium. Biol Reprod. 2009; 80 (6). 1136-1145
15. Masuda H, Matsuzaki Y, Hiratsu E, et al. Stem cell-like properties of the endometrial side population: implication in endometrial regeneration. PLoS ONE. 2010; 5 (4). e10387
16. Cervelló I, Gil-Sanchis C, Mas A, et al. Human endometrial side population cells exhibit genotypic, phenotypic and functional features of somatic stem cells. PLoS ONE. 2010; 5 (6). e10964
17. Cervelló I, Mas A, Gil-Sanchis C, et al. Reconstruction of endometrium from human endometrial side population cell lines. PLoS ONE. 2011; 6 (6). e21221
18. Oliveira FR, Dela Cruz C, Del Puerto HL, Vilamil QT, Reis FM, Camargos AF. Stem cells: are they the answer to the puzzling etiology of endometriosis?. Histol Histopathol. 2012; 27 (1). 23-29
19. Sasson IE, Taylor HS. Stem cells and the pathogenesis of endometriosis. Ann N Y Acad Sci. 2008; 1127: 106-115
20. Gargett CE. Uterine stem cells: what is the evidence?. Hum Reprod Update. 2007; 13 (1). 87-101
21. Starzinski-Powitz A, Zeitvogel A, Schreiner A, Baumann R. In search of pathogenic mechanisms in endometriosis: the challenge for molecular cell biology. Curr Mol Med. 2001; 1 (6). 655-664
22. Gargett CE, Nguyen HP, Ye L. Endometrial regeneration and endometrial stem/progenitor cells. Rev Endocr Metab Disord. 2012; 13 (4). 235-51
23. Giudice LC. Clinical practice. Endometriosis. N Engl J Med. 2010; 362 (25). 2389-2398
24. Forte A, Schettino MT, Finicelli M, et al. Expression pattern of stemness-related genes in human endometrial and endometriotic tissues. Mol Med. 2009; 15 (11-12). 392-401
25. Fauconnier A, Chapron C. Endometriosis and pelvic pain: epidemiological evidence of the relationship and implications. Hum Reprod Update. 2005; 11 (6). 595-606
26. Seli E, Berkkanoglu M, Arici A. Pathogenesis of endometriosis. Obstet Gynecol Clin North Am. 2003; 30 (1). 41-61
27. Sampson JA. Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol. 1927; 14: 422-469
28. Nisolle M, Donnez J. Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of rectovaginal septum are three different entities. Fertil Steril. 1997; 68 (4). 585-596
29. D'Hooghe TM, Debrock S. Endometriosis, retrograde menstruation and peritoneal inflammation in women and in baboons. Hum Reprod Update. 2002; 8 (1). 84-88
30. Kruitwagen RF, Poels LG, Willemsen WN, Jap PH, Thomas CM, Rolland R. Retrograde seeding of endometrial cells by uterine-tubal flushing. Fertil Steril. 1991; 56 (3). 414-420
31. Stefansson H, Geirsson RT, Steinthorsdottir V, et al. Genetic factors contribute to the risk of developing endometriosis. Hum Reprod. 2002; 17 (3). 555-559
32. Christodoulakos G, Augoulea A, Lambrinoudaki I, Sioulas V, Creatsas G. Pathogenesis of endometriosis: the role of defective " immunosorveillance". Eur J Contracept Reprod Health Care. 2007; 12 (3). 194-202
33. Viganò P, Somigliana E, Vignali M, Busacca M, Blasio AM. Genetics of endometriosis: current status and prospects. Front Biosci. 2007; 12: 3247-3255
34. Signorile P, Baldi A. Endometriosis: new concepts in the pathogenesis. Int J Biochem Cell Biol. 2010; 42 (6). 778-780
35. Ferguson BR, Bennington JL, Haber SL. Histochemistry of mucosubstances and histology of mixed mullerian pelvic lymph node glandular inclusion: evidence for histogenesis by mullerian metaplasia of coelomic epithelium. Obstet Gynecol. 1969; 33 (5). 617-625
36. Matssura K, Ohtake H, Katabuchi H, Okamura H. Coelomic metaplasia theory of endometriosis: evidence from in vivo studies and an in vitro experimental model. Gynecol Obstet Invest. 1999; 47 (suppl 1). 18-20
37. Sampson JA. Heterotopic or misplaced endometrial tissue. Am J Obstet Gynecol. 1925; 10: 649-664
38. Keichel S, Barcena de Arellano ML, Reichelt U, et al. Lymphangiogenesis in deep infiltrating Endometriosis. Hum Reprod. 2011; 26 (10). 2713-2720
39. Fraser IS. Recognising, understanding and managing endometriosis. J Hum Reprod Sci. 2008; 1 (2). 56-64
40. Spencer TE, Hayashi K, Hu J, Carpenter KD. Comparative developmental biology of the mammalian uterus. Curr Top Dev Biol. 2005; 68: 85-122
41. Maruyama T, Yoshimura Y. Molecular and cellular mechanisms for differentiation and regeneration of the uterine endometrium. Endocr J. 2008; 55 (5). 795-810
42. Salamonsen LA, Kovacs GT, Findlay JK. Current concepts of the mechanisms of menstruation. Baillieres Best Pract Res Clin Obstet Gynaecol. 1999; 13 (2). 161-179
43. Kaitu'u-Lino TJ, Gargett CE. Reepithelization of the uterine surface arises from endometrial glands: evidence from a functional mouse model of breakdown and repair. Endocrinology. 2010; 151 (7). 3386-3395
44. Leyendecker G, Herbertz M, Kunz G, Mall G. Endometriosis results from the dislocation of basal endometrium. Hum Reprod. 2002; 17 (10). 2725-2736
45. Weissman IL. Stem cells: scientific, medical, and political issues. N Engl J Med. 2002; 346 (20). 1576-1579
46. Figueira PG, Abrao MS, Krikun G, Taylor HS. Stem cells in endometrium and their role in the pathogenesis of endometriosis. Ann N Y Acad Sci. 2011; 1221: 10-17
47. Chamberlain G, Fox J, Ashton B, et al. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells. 2007; 25 (11). 2739-2749
48. Korbling M, Estrov Z. Adult stem cells for tissue repair: a new therapeutic concept?. N Engl J Med. 2003; 349 (6). 570-582
49. Gargett CE. Stem cells in gynaecology. Aust N Z J Obstet Gynaecol. 2004; 44 (5). 380-386
50. Matthai C, Horvat R, Noe M. Oct-4 expression in human endometrium. Mol Hum Reprod. 2006; 12 (1). 7-10
51. Chambers I, Tomlinson SR. The transcriptional foundation of pluripotency. Development. 2009; 136 (14). 2311-2322
52. Tai MH, Chang CC, Kiupel M. Expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis. 2005; 26 (2). 495-502
53. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med. 1996; 183 (4). 1797-1806
54. Schwab KE, Gargett CE. Co-expression of two perivascular cell markers isolates mesenchymal stem-like cells from human endometrium. Hum Reprod. 2007; 22 (11). 2903-2911
55. Maruyama T, Masuda H, Ono M. Human uterine stem/progenitor cells: their possible role in uterine physiology and pathology. Reprod. 2010; 140 (1). 11-22
56. Nguyen HP, Sprung CN, Gargett CE. Differential expression of Wnt signaling molecules between pre-and postmenopausal endometrial epithelial cells suggests a population of putative epithelial stem/progenitor cells reside in the basalis layer. Endocrinology. 2012; 153 (6). 2870-2883
57. Du H, Taylor HS. Stem cells and female reproduction. Reprod Sci. 2009; 16 (2). 127-139
58. Aghajanova L, Horcajadas JA, Hesteban FJ, Giudice LC. The bone marrow-derived human mesenchymal stem cell: potential progenitor of the endometrial stromal fibroblast. Biol Reprod. 2010; 82 (6). 1076-1087
59. Du H, Taylor HS. Contribution of bone marrow-derived stem cells to endometrium and endometriosis. Stem Cells. 2007; 25 (8). 2082-2086
60. Meng X, Ichim TE, Zhong J. A novel stem cell population. J Transl Med. 2007; 5: 57
61. Moggio A, Pittatore G, Cassoni P, Marchino GL, Revelli A, Bussolati B. Sorafenib inhibits growth, migration, and angiogenic potential of ectopic endometrial mesenchymal stem cells derived from patients with endometriosis. Fertil Steril. 2012; 98 (6). 1521-1530
62. Schwab KE, Hutchinson P, Gargett CE. Identification of surface markers for prospective isolation of human endometrial stromal colony-forming cells. Hum Reprod. 2008; 23 (4). 934-943
63. D'Hooghe TM, Bambra CS, De Jonge I, Lauweryns JM, Koninckx PR. The prevalence of spontaneous endometriosis in the baboon (Papio anubis, Papio cynocephalus) increases with the time spent in captivity. Acta Obstet Gynecol Scand. 1996; 75 (2). 98-101
64. Braundmeier AG, Fazleabas AT. The non-human primate model of endometriosis: research and implications for fecundity. Mol Hum Reprod. 2009; 15 (10). 577-586
65. D'Hooghe TM, Kyama CM, Chai D, et al. Nonhuman primate models for translational research in endometriosis. Reprod Sci. 2009; 16 (2). 152-161
66. Masuda H, Maruyama T, Hiratsu E. Noninvasive and real-time assessment of reconstructed functional human endometrium in NOD/SCID/c (null) immunodeficient mice. Proc Natl Acad Sci USA. 2007; 104 (6). 1925-1930
67. Grümmer R. Animal model in endometriosis research. Hum Reprod Update. 2006; 12 (5). 641-649
68. Nisolle M, Casanas-Roux F, Donnez J. Early-stage endometriosis: adhesion and growth of human menstrual endometrium in nude mice. Fertil Steril. 2000; 74 (2). 306-312
69. Grümmer R, Schwarzer F, Bainczyk K, et al. Peritoneal endometriosis: validation of an in-vivo model. Hum Reprod. 2001; 16 (8). 1736-1743
70. Pacchiarotti A, Caserta D, Sbracia M, Moscarini M. Expression of oct-4 and c-kit antigens in endometriosis. Fertil Steril. 2011; 95 (3). 1171-1173
71. Götte M, Wolf M, Staebler A, et al. Increased expression of the adult stem cell marker Musashi-I in endometriosis and endometrial carcinoma. J Pathol. 2008; 215 (3). 317-329
72. Chan RW, Ng EH, Yeung WS. Identification of cells with colony-forming activity, self-renewal capacity, and multipotency in ovarian endometriosis. Am J Pathol. 2011; 178 (6). 2832-2844
73. Ornek T, Fadiel A, Tan O, Naftolin F, Arici A. Regulation and activation of Ezrin protein in endometriosis. Hum Reprod. 2008; 23 (9). 2104-2112
74. Meng X, Ichim TE, Zhong J. Endometrial regenerative cells: a novel stem cell population. J Transl Med. 2007; 15: 5
75. Herington JL, Bruner-Tran KL, Lucas JA, Osteen KG. Immune interactions in endometriosis. Expert Rev Clin Immunol. 2011; 7 (5). 611-626
76. Khan NK, Kitajima M. Immunopathogenesis of pelvic endometriosis: role of hepatocyte growth factor, macropahge and ovarian steroids. AJRI. 2008; 60 (5). 383-404
77. Bussolati B, Deregibus MC, Camussi G. Characterization of molecular and functional alterations of tumor endothelial cells to design anti-angiogenic strategies. Curr Vasc Pharmacol. 2010; 8 (2). 220-232
78. Nap AW, Griffioen AW, Dunselman GA, et al. Antiangiogenesis therapy for endometriosis. J Clin Endocrinol Metab. 2004; 89 (3). 1089-1095
79. Soares SR, Martinez-Varea A, Hidalgo-Mora JJ. Pharmacologic therapies in endometriosis: a systematic review. Fertil Steril. 2012; 98 (3). 529-555
80. McLaren J. Vascular endothelial growth factor and endometriotic angiogenesis. Hum Reprod Update. 2000; 6 (1). 45-55
81. Bourlev V, Volkov N, Pavlovitch S, Lets N, Larsson A, Olovsson M. The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions. Reprod. 2006; 132 (3). 501-509
82. Wilhelm SM, Carter C, Tang L, et al. BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis. Cancer Res. 2004; 64 (19). 7099-7109
83. Pignochino Y, Grignani G, Cavalloni G, et al. Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways. Mol Cancer. 2009; 8: 118
84. Iyer R, Fetterly G, Lugade A, Thanavala Y. Sorafenib: a clinical and pharmacologic review. Expert Opin Pharmacother. 2010; 11 (11). 1943-1955
85. Nilsson MB, Zage PE, Zeng L, et al. Multiple receptor tyrosine kinases regulate HIF-1alpha and HIF-2alpha in normoxia and hypoxia in neuroblastoma: implications for antiangiogenic mechanism of multikinase inhibitors. Oncogene. 2010; 29 (20). 2938-2949
86. Ricci AG, Olivares CN, Bilotas MA. Effect of vascular endothelial growth factor inhibition on endometrial implant development in a murine model of endometriosis. Reprod Sci. 2011; 18 (7). 614-622
87. Laschke MW, Elitzsch A, Vollmar B, et al. Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessels maturation in endometriotic lesion. Hum Reprod. 2006; 21 (1). 262-268
88. Ozer H, Boztosun A, Açmaz G, Atilgan R, Akkar OB, Kosar MI. The efficacy of bevacizumab, sorafenib, and retinoic acid on rat endometriosis model. Reprod Sci. 2013; 20 (1). 26-32
89. Dabrosin C, Gyorffy S, Margetts P, Ross C, Gauldie J. Therapeutic effect of angiostatin gene transfer in a murine model of endometriosis. Am J Pathol. 2002; 161 (3). 909-918
90. Novella-Maestre E, Carda C, Noguera I, et al. Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenensis in experimentally induced endometriosis. Hum Reprod. 2009; 24 (5). 1025-1035
91. Novella-Maestre E, Carda C, Ruiz-Sauri A, Garcia-Velasco JA, Simon C, Pellicer A. Identification and qualification of dopamine receptor 2 in human eutopic and ectopic endometrium: a novel molecular target for endometriosis therapy. Biol Reprod. 2010; 83 (5). 866-873